Table 1.
Baseline characteristics by treatment group for completers.
| Modafinil | Placebo | Total | |
|---|---|---|---|
| Number (%) | |||
| Female sex | 4 (66.66%) | 3 (75.00%) | 7 (70.00%) |
| BD I diagnosis | 6 (100.00%) | 3 (75.00%) | 9 (90.00%) |
| Race – White | 4 (66.66%) | 1 (25.00%) | 5 (50.00%) |
| Race – Black | 2 (33.33%) | 3 (75.00%) | 5 (50.00%) |
| Ethnicity – Hispanic | 0 (0%) | 1 (25.00%) | 1 (10.00%) |
| Mean (SD) | |||
| Age | 51.33 (11.15) | 44.00 (13.29) | 48.40 (11.93) |
| Years of education | 15.00 (2.10) | 14.50 (1.92) | 14.80 (1.93) |
| Hamilton Depression Rating Scale (HDRS) | 6.67 (3.08) | 7.75 (4.35) | 7.10 (3.45) |
| Clinician-Administered Rating Scale for Mania (CARS-M) | 2.83 (3.06) | 0.75 (0.96) | 2.00 (2.58) |
| Composite cognitive functioning | 42.17 (14.43) | 40.25 (11.44) | 41.40 (12.66) |
| Speed of processing | 45.00 (15.28) | 53.00 (12.03) | 48.20 (13.97) |
| Attention/vigilance | 45.00 (10.90) | 36.00 (15.19) | 41.40 (12.83) |
| Working memory | 39.33 (16.13) | 43.00 (8.37) | 40.80 (13.10) |
| Verbal learning | 46.50 (8.36) | 43.25 (7.81) | 45.20 (7.87) |
| Visual learning | 47.00 (13.70) | 45.00 (11.17) | 46.20 (12.12) |
| Reasoning and problem solving | 46.00 (10.73) | 41.75 (5.12) | 44.30 (8.81) |
| Social cognition | 47.00 (1.90) | 46.25 (12.04) | 46.70 (7.10) |
| Pittsburgh Sleep Quality Index (PSQI) | 11.00 (4.52) | 11.50 (3.11) | 11.20 (3.82) |
| Epworth Sleepiness Scale (ESS) | 6.33 (6.25) | 13.75 (3.50) | 9.30 (6.36) |